Skip to main content

An experienced leadership team

Our leadership team understands the complexities of antibody engineering, cancer biology, immunology, cell-line and bioprocess development, purification process development, characterization, analytical and formulation development, and quality control and stability studies. They have a proven track record of innovation and success, including numerous issued patents. These leaders have led the development of multiple biotherapies that progressed to clinical testing.

Wei Yan, Ph.D.

Chief Executive Officer

View Bio

Phillip Liu, M.D.

Sr. Director, Protein Engineering

View Bio

Sarah Headland, Ph.D.

Director, Biology

View Bio

Sean Huang, Ph.D.

Director, Biopharm Sciences

View Bio

Jelle W. Kijlstra, M.D., MBA

Medical Advisor

View Bio

Ronald Schoner, Ph.D.

Consultant, Bioprocess Sciences

View Bio